# Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

> **NCT01427868** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 32 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** LB80380 maleate salt
- **DRUG:** LB80380 free base

## Key facts

- **NCT ID:** NCT01427868
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427868, "Bioequivalence of LB80380 Free Base and Maleate Salt Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01427868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*